John Mendlein

Insider Reports History

Entity
Individual
Signature
/s/ Barbara Chan as Attorney-in-Fact for John Mendlein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Mendlein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
FATE THERAPEUTICS INC Director Stock Option (Right to Buy) 40K $109K $2.73 Jun 7, 2024 Direct
Omega Therapeutics, Inc. Director Stock Option (Right to Buy) 25K Jun 20, 2024 Direct

Insider Reports Filed by John Mendlein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OMGA Omega Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
FATE FATE THERAPEUTICS INC Jun 7, 2024 1 $0 4 Jun 11, 2024 Director
OMGA Omega Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
FATE FATE THERAPEUTICS INC Jun 6, 2023 1 $0 4 Jun 7, 2023 Director
FATE FATE THERAPEUTICS INC Jan 19, 2023 2 $39K 4 Jan 20, 2023 Director
FATE FATE THERAPEUTICS INC Jan 11, 2023 2 $698K 4 Jan 13, 2023 Director
FATE FATE THERAPEUTICS INC Jun 9, 2022 2 $0 4 Jun 13, 2022 Director
OMGA Omega Therapeutics, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
FATE FATE THERAPEUTICS INC Jun 3, 2022 1 -$31.1K 4 Jun 6, 2022 Director
FATE FATE THERAPEUTICS INC Mar 10, 2022 4 -$1.05M 4 Mar 11, 2022 Director
OMGA Omega Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director
FATE FATE THERAPEUTICS INC Jun 2, 2021 2 $0 4 Jun 4, 2021 Director